Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

NCT06603311 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT06603311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06603311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection
Lead sponsor
Hannover Medical School
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2024
Completion date
June 30, 2026
Enrollment
20 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

compensated liver disease (disorder), hepatitis d, chronic